Page 3,870«..1020..3,8693,8703,8713,872..3,8803,890..»

Stem cell agency tightens ethics rules

Posted: Published on July 25th, 2014

Stem cell agency President C. Randal Mills (left) and Chairman of the Board Jonathan Thomas. Responding to his predecessor's ethically controversial departure, the president and chief executive of California's stem cell agency said Thursday he is taking legal steps to minimize conflicts of interests with those who have business before the agency. C. Randal Mills said he will not take a job with any company funded by the California Institute for Regenerative Medicine for one year after he departs the agency. In addition, he also will not accept gifts or travel payments from any company, institution or person who gets agency funding. Mills' action, announced at the agency's meeting in Millbrae, will be enforced with a legal agreement he will sign. His action comes less than a month after he replaced Alan Trounson as the agency chief. One week after his departure, CIRM-funded StemCells Inc. announced it had appointed Trounson to its board. StemCells Inc. had received an award of nearly $20 million from the agency to develop a therapy for Alzheimers disease. While Trounson's appointment wasn't illegal, critics said it was unseemly for him to join a company that had received agency funding so soon after he left CIRM. … Continue reading →

Comments Off on Stem cell agency tightens ethics rules

Robert J. Harman, DVM, Founder and CEO of Vet-Stem, Inc. to Join New York Radio Host Lorry Young in Upcoming Episode …

Posted: Published on July 25th, 2014

San Diego, CA (PRWEB) July 25, 2014 WABC Radio show out of New York City, A Paws For Your Pet with Lorry Young will be hosting California-based Vet-Stem, Inc.s Founder and CEO, Robert J. Harman, DVM, to talk about stem cell therapy in pets. Dr. Harman first visited the show in November 2013 to discuss the benefits of stem cell therapy for pets suffering from osteoarthritis and other degenerative diseases, as well as recent developments moving the Regenerative Veterinary Medicine industry forward. Young has invited Dr. Harman back to dial down into specific case studies and success stories of the over 10,000 dogs, cats, horses and exotic animals that Vet-Stems services have treated in the last decade. Moose, a Labrador Retriever Mix, is one of those special pet patients in the New York City area that was treated with Vet-Stem Regenerative Cell Therapy for arthritis caused by elbow dysplasia, and arthritic bone growth. When Mooses owners noticed decreased mobility, lameness, and an increasingly lower tolerance for other dogs they brought Moose to local veterinarian Alex Klein to explore solutions. As many as 65% of dogs between the ages of 7 and 11 years old are inflicted with some degree of … Continue reading →

Comments Off on Robert J. Harman, DVM, Founder and CEO of Vet-Stem, Inc. to Join New York Radio Host Lorry Young in Upcoming Episode …

magforce – Using advanced nanomedicine for innovative therapies – Video

Posted: Published on July 25th, 2014

magforce - Using advanced nanomedicine for innovative therapies Extending the role of nanomedicine in cancer treatment Every year, more than 10 million people worldwide are diagnosed with cancer for the first time. The World Health Organization estimates... By: Magforce AG … Continue reading →

Comments Off on magforce – Using advanced nanomedicine for innovative therapies – Video

SPS Attack in Hotel Prior to Stem Cell Transplant – Video

Posted: Published on July 25th, 2014

SPS Attack in Hotel Prior to Stem Cell Transplant I had this attack on my first day in Denver preparing for my stem cell transplant. These occurred daily to some degree until day +2 after receiving my stem c... By: StiffPersonSyndrome … Continue reading →

Posted in Stem Cell Transplant | Comments Off on SPS Attack in Hotel Prior to Stem Cell Transplant – Video

Top journal retracts stem-cell study

Posted: Published on July 25th, 2014

Leading science journal Nature is withdrawing a stem-cell study published in January that had been hailed as a 'game-changer' in the quest to grow transplant tissue. The announcement on Wednesday came after mistakes were discovered in some data published in two papers, photograph captions were found to be misleading, and the work itself could not be repeated by other scientists, it said. 'All co-authors of both papers have finally concluded that they cannot stand behind the papers, and have decided to retract them,' the journal said in an editorial. Nature said it would tighten up procedures to vet future studies submitted for publication. On June 4, Japan's Riken research institute said lead scientist Haruko Obotaka, 30, had agreed to retract the papers after an investigation. Obokata was feted after unveiling findings that appeared to show a straight-forward way to reprogram adult cells to become stem cells - precursors that are capable of developing into any other cell in the human body. Identifying a readily-manufacturable supply of stem cells could one day help meet a need for transplant tissues, or even whole organs. See the original post here: Top journal retracts stem-cell study … Continue reading →

Posted in Stem Cell Transplant | Comments Off on Top journal retracts stem-cell study

Khongkwan Clinic inks pact with medical centres in 6 markets

Posted: Published on July 25th, 2014

The move is aimed at cashing in on the implementation of the Asean Economic Community, which comes into effect next year, and to contribute to the country's potential of being a hub for medical services in the region. Under the cooperation pact - signed with medical service centres and beauty clinics in South Korea, Germany, Italy, France, Singapore and the US - Thailand can be promoted as a global medical hub within the next three years, thanks to its lower cost of medical treatment and post-surgery rehabilitation, said Dr Khongkwan Fujitnirun, laser surgeon and managing director of Khongkwan Clinic. The deal will increase the number of foreign patients at the company's beauty clinics, she added. "With this cooperation, we will be able to share special skills on aesthetic medical services with our partners in other countries. South Korea, for example, has very strong expertise in cosmetic surgery, and Germany in live-cell treatment. "For Khongkwan Clinic, we aim to increase our foreign patient contribution from just 10 per cent currently to about 35 per cent by the end of next year," said Khongkwan. Celebrating its eighth anniversary this year, Khongkwan Clinic has 14 outlets, of which 13 are in Thailand - … Continue reading →

Posted in Aesthetic Surgery | Comments Off on Khongkwan Clinic inks pact with medical centres in 6 markets

Joslin Scientists Create the First IPS Cells to Offer Human Model of Insulin Resistance

Posted: Published on July 25th, 2014

Contact Information Available for logged-in reporters only Newswise BOSTON July 24, 2014 Japanese biologist Shinya Yamanaka won a Nobel Prize in 2012 for discovering how to create induced pluripotent stem cells (iPSCs), cells derived from normal adult cells that have the ability to differentiate into almost any other kind of cells. Scientists at Joslin Diabetes Center now have created the first iPSCs that offer a human model of insulin resistance, a key driver of type 2 diabetes. This is one of the very first studies of human iPSC models for type 2 diabetes, and it points out the power of this technology to look at the nature of diabetes, which is complex and may be different in different individuals, says C. Ronald Kahn, MD, Joslins Chief Academic Officer and the Mary K. Iacocca Professor of Medicine at Harvard Medical School. Until now, scientists examining the causes and effects of insulin resistance have struggled with a general lack of human cell lines from tissues such as muscle, fat and liver that respond significantly to insulin, Kahn says. Studying insulin resistance as it progresses through pre-clinical stages of type 2 diabetes has been particularly challenging. There have been no good human cell … Continue reading →

Posted in Stem Cell Human Trials | Comments Off on Joslin Scientists Create the First IPS Cells to Offer Human Model of Insulin Resistance

FUE Surgery1800 grafts Narendra – Video

Posted: Published on July 25th, 2014

FUE Surgery1800 grafts Narendra Mr Narendra Kaushik opted for FUE 1800 grafts at Satya hair Transplant Clinc Delhi. By: Satya Hair Transplant Clinic | Hair Loss Treatment | Stem Cell Treatment … Continue reading →

Comments Off on FUE Surgery1800 grafts Narendra – Video

MS stem cell therapy treatment hope for mum

Posted: Published on July 25th, 2014

July 24, 2014, 10:29 p.m. A 60 MINUTES report on new multiple sclerosis stem cell therapy has thrown Wendouree mum Kathryn Johnston a potential lifeline. A 60 MINUTES report on new multiple sclerosis stem cell therapy has thrown Wendouree mum Kathryn Johnston a potential lifeline. Hopeful: Wendouree mum Kathryn Johnston is hoping new stem cell therapy treatment will help her be a more active mother to her daughter Dellah, 7. PICTURE: KATE HEALY Ms Johnston, who has had MS for 15 years, is hoping the treatment will help her be a more active mother to daughter Dellah, 7. I cant do a great deal with my daughter now but its also the unknown not knowing if Ill wake up one day and not be able to walk, Ms Johnston said. The 35-year-old emergency nurse hopes to travel to Russia in August next year for the treatment, which involves extracting her stem cells, freezing them while she undergoes a strong course of chemotherapy and then replacing them. It gets rid of any underlying MS and rebuilds the immune system from scratch. As a general rule, its been about 80 per cent effective. Ms Johnston first noticed her MS symptoms as an … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on MS stem cell therapy treatment hope for mum

StemGenex Gives Hope to Parkinsons Patients through New Stem Cell Clinical Study

Posted: Published on July 25th, 2014

La Jolla, CA (PRWEB) July 23, 2014 StemGenex, the leading resource for adult adipose stem cell therapy in the US aimed at improving the lives of patients dealing with degenerative diseases today announced their newest clinical study for Parkinsons disease. StemGenex believes that a commitment to the safety and efficacy of stem cell therapy are paramount when providing care to patients with degenerative diseases. This clinical study makes stem cell therapy accessible to the millions of individuals currently living with Parkinsons disease. The protocol used in these stem cell treatments is unique to StemGenex, having the possibility of being more effective than other stem cell treatments currently available. StemGenex has developed a multiple administration protocol for patients suffering from Parkinsons disease which includes targeted methods of stem cell delivery. Among these methods is a novel approach for delivering stem cells past the blood brain barrier an issue most stem cell treatments have been challenged by. Principal Investigator Dr. Jeremiah McDole, Ph.D. stated, As is the case with most neurodegenerative conditions, there are few available drugs to treat Parkinsons disease. The handful of drugs that are available can only ameliorate symptoms and unfortunately, prolonged usage can create terrible side-effects. Further, these … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on StemGenex Gives Hope to Parkinsons Patients through New Stem Cell Clinical Study

Page 3,870«..1020..3,8693,8703,8713,872..3,8803,890..»